What is the home dose of Eliquis (apixaban) 2.5 mg orally (po) twice daily (bid) after knee surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Home Dosing of Eliquis (Apixaban) 2.5 mg After Knee Surgery

The home dose of Eliquis (apixaban) for VTE prophylaxis after knee replacement surgery is 2.5 mg orally twice daily for 12 days total, with the first dose initiated 12-24 hours after surgery. 1

Standard Dosing Protocol

  • Dose: 2.5 mg taken orally twice daily 1
  • Duration: 12 days for knee replacement surgery (compared to 35 days for hip replacement) 1, 2
  • Timing of first dose: 12-24 hours after surgery 1
  • When to resume: Only after adequate hemostasis has been established 2, 3

Key Considerations for Safe Home Discharge

Renal Function Monitoring

  • Surgical procedures can affect renal function postoperatively, which impacts apixaban elimination 2
  • Creatinine clearance should be assessed, as apixaban has a half-life of 7-8 hours in patients with normal renal function 4
  • Patients with moderate renal impairment (CrCl 30-50 mL/min) may require extended monitoring 3

Patient Education on Missed Doses

  • If a dose is missed, take it as soon as possible on the same day 1
  • Resume twice-daily administration as scheduled 1
  • Never double the dose to make up for a missed dose 1

Bleeding Risk Assessment

  • Individual bleeding risk should be considered when determining exact timing of the first dose 2
  • Monitor for signs of major bleeding, though the risk is low with this prophylactic regimen 5
  • Clinically relevant nonmajor bleeding occurs in approximately 4.8% of patients on apixaban 6

Common Pitfalls to Avoid

Inadequate Duration

  • Do not stop prophylaxis early - the full 12-day course is necessary for knee replacement 2
  • Premature discontinuation increases VTE risk without reducing bleeding complications 2

Drug Interactions

  • Avoid concomitant strong P-glycoprotein inhibitors and CYP3A4 inhibitors without dose adjustment 2
  • These interactions can significantly increase apixaban levels and bleeding risk 3

Overlapping Anticoagulation

  • If the patient was on anticoagulation preoperatively, ensure proper transition without overlap 2
  • Do not administer apixaban simultaneously with other anticoagulants unless specifically bridging under protocol 1

Neuraxial Anesthesia Considerations

  • If an epidural catheter was used, special timing considerations apply for apixaban administration 2
  • Ensure adequate time has elapsed since catheter removal before initiating apixaban 3

Alternative Immediate Postoperative Options

  • If immediate VTE prophylaxis is needed before apixaban can be safely started, heparin or fondaparinux can be administered at least 6 hours after the procedure 2, 3
  • Transition to apixaban once hemostasis is confirmed 3

Efficacy Data

  • In a large multicenter study of 5,017 bariatric patients, the 2.5 mg twice daily regimen for 30 days resulted in only 0.1% thromboembolic complications when the protocol was followed 5
  • No deaths or thromboembolic events occurred when the full protocol was completed 5

References

Guideline

Apixaban Dosing After Hip Procedure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Perioperative Management of Apixaban for Orthopedic Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Apixaban for Extended Treatment of Provoked Venous Thromboembolism.

The New England journal of medicine, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.